STRATEGIC ARRANGEMENTS (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Aug. 02, 2017 |
Dec. 01, 2007 |
Jun. 30, 2020 |
Jun. 30, 2019 |
Jun. 30, 2020 |
Dec. 31, 2019 |
|
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
| Minimum annual royalty payment | $ 500,000 | |||||
| CASE | ||||||
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
| Royalty expense | $ 24,000 | $ 37,000 | ||||
| Royalty payable | $ 24,000 | $ 24,000 | $ 39,000 | |||
| Royalty Agreement Terms | CASE | ||||||
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
| Royalty agreement period | 10 years | 10 years | ||||
| Minimum annual royalty payment | $ 10,000 | |||||
| Royalty agreement percentage | 3.00% | |||||
| Milestone payments for FDA approval to sell our products within the United States | $ 5,000 | |||||
| Milestone payment for general product launch | $ 10,000 | |||||